{"DataElement":{"publicId":"7449287","version":"1","preferredName":"Gallbladder Cancer AJCC Edition 8 Clinical Tumor T Category","preferredDefinition":"Extent of the primary gallbladder carcinoma based on clinical findings using AJCC Ed. 8 criteria.","longName":"GBC_AJC8_CLN_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2452446","version":"2","preferredName":"Gallbladder Neoplasm Clinical T Category","preferredDefinition":"A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"2452440v1.0:2207100v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452440","version":"1","preferredName":"Gallbladder Neoplasm","preferredDefinition":"A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12377:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder","conceptCode":"C12377","definition":"A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6541-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B07497FD-CF93-4D26-E053-4EBD850AAD28","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-09-29","changeDescription":"9.29.20 TL transferred context from CTEP to NCI Standards, unretired and versioned DEC to 2.0 (restored Long and Short Names). Orphan DEC Retired Archived as part of caBIG effort to retire orphan Administered Components 01-01-2013 djs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7448910","version":"1","preferredName":"Gallbladder Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of gallbladder cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)_One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"7448910v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Gallbladder Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"7448912","version":"1","preferredName":"Gallbladder Cancer pT4 TNM Finding v8","longName":"7448912","preferredDefinition":"Gallbladder cancer with tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT4 TNM Finding v8","conceptCode":"C134654","definition":"Gallbladder cancer with tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-287B-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-2894-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T3","valueDescription":"Gallbladder Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"7448914","version":"1","preferredName":"Gallbladder Cancer pT3 TNM Finding v8","longName":"7448914","preferredDefinition":"Gallbladder cancer with tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT3 TNM Finding v8","conceptCode":"C134653","definition":"Gallbladder cancer with tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-28A1-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-28BA-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T2b","valueDescription":"Gallbladder Cancer pT2b TNM Finding v8","ValueMeaning":{"publicId":"7448916","version":"1","preferredName":"Gallbladder Cancer pT2b TNM Finding v8","longName":"7448916","preferredDefinition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT2b TNM Finding v8","conceptCode":"C134652","definition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-28C7-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-28E0-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T2a","valueDescription":"Gallbladder Cancer pT2a TNM Finding v8","ValueMeaning":{"publicId":"7448918","version":"1","preferredName":"Gallbladder Cancer pT2a TNM Finding v8","longName":"7448918","preferredDefinition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT2a TNM Finding v8","conceptCode":"C134651","definition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-28ED-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-2906-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"Gallbladder Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"7448920","version":"1","preferredName":"Gallbladder Cancer pT2 TNM Finding v8","longName":"7448920","preferredDefinition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT2 TNM Finding v8","conceptCode":"C134650","definition":"Gallbladder cancer with tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-2913-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-292C-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Gallbladder Cancer pT1b TNM Finding v8","ValueMeaning":{"publicId":"7448922","version":"1","preferredName":"Gallbladder Cancer pT1b TNM Finding v8","longName":"7448922","preferredDefinition":"Gallbladder cancer with tumor invading the muscular layer. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT1b TNM Finding v8","conceptCode":"C134649","definition":"Gallbladder cancer with tumor invading the muscular layer. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-2939-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-2952-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Gallbladder Cancer pT1a TNM Finding v8","ValueMeaning":{"publicId":"7448924","version":"1","preferredName":"Gallbladder Cancer pT1a TNM Finding v8","longName":"7448924","preferredDefinition":"Gallbladder cancer with tumor invading the lamina propria. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT1a TNM Finding v8","conceptCode":"C134648","definition":"Gallbladder cancer with tumor invading the lamina propria. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-295F-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-2978-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"Gallbladder Cancer pT1 TNM Finding v8","ValueMeaning":{"publicId":"7448926","version":"1","preferredName":"Gallbladder Cancer pT1 TNM Finding v8","longName":"7448926","preferredDefinition":"Gallbladder cancer with tumor invading the lamina propria or muscular layer. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT1 TNM Finding v8","conceptCode":"C134647","definition":"Gallbladder cancer with tumor invading the lamina propria or muscular layer. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-2985-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-299E-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Gallbladder Cancer pTis TNM Finding v8","ValueMeaning":{"publicId":"7448928","version":"1","preferredName":"Gallbladder Cancer pTis TNM Finding v8","longName":"7448928","preferredDefinition":"Gallbladder cancer with a finding of carcinoma in situ. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pTis TNM Finding v8","conceptCode":"C134646","definition":"Gallbladder cancer with a finding of carcinoma in situ. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-29AB-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-29C4-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"T0","valueDescription":"Gallbladder Cancer pT0 TNM Finding v8","ValueMeaning":{"publicId":"7448930","version":"1","preferredName":"Gallbladder Cancer pT0 TNM Finding v8","longName":"7448930","preferredDefinition":"Gallbladder cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pT0 TNM Finding v8","conceptCode":"C134645","definition":"Gallbladder cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-29D1-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-29EA-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"TX","valueDescription":"Gallbladder Cancer pTX TNM Finding v8","ValueMeaning":{"publicId":"7448932","version":"1","preferredName":"Gallbladder Cancer pTX TNM Finding v8","longName":"7448932","preferredDefinition":"Gallbladder cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer pTX TNM Finding v8","conceptCode":"C134644","definition":"Gallbladder cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-29F7-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B076E199-2A10-6939-E053-4EBD850AAC9C","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7448909","version":"1","preferredName":"Gallbladder Cancer TNM Finding v8 T Category Category","preferredDefinition":"A finding about one or more characteristics of gallbladder cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.):One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C134635:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer TNM Finding v8","conceptCode":"C134635","definition":"A finding about one or more characteristics of gallbladder cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B076E199-284E-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B076E199-285F-6939-E053-4EBD850AAC9C","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-09-30","changeDescription":"TL created for standardization; requested by ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"7448902","version":"1","longName":"Gallbladder","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T category","type":"Preferred Question Text","description":"Clinical T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B077D89A-C5B6-6537-E053-4EBD850AA388","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-09-30","changeDescription":"TL created for standardization; requested by ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}